| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |